Pentobarbital will minimize the extent or result of fentanyl transmucosal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Coadministration of fentanyl with CYP3A4 inducers could lead to a decrease in fentanyl plasma concentrations, not enough efficacy or, perhaps, development of the withdrawal syndrome in a affected person who's got https://jessicaj764xip4.daneblogger.com/profile